Conclusion
MINST, PD, periodontitis
REGRESSION, PERIODONTITIS, BONE LOSS
MINST and standard non-surgical periodontal debridement resulted in significant but comparable decreases in the number of sites with PD ≥ 5 mm + BOP and other clinical parameters. Furthermore, in a multilevel, multivariate logistic regression model, male gender and molar teeth were related to a higher number of residual sites with PD ≥ 5 mm + BOP. Therefore, within the scope of this study, it is reasonable to state that the MINST regimen is a clinically beneficial initial non-surgical treatment for stage III periodontitis characterised by predominantly supraalveolar bone loss, yielding results comparable to the classical treatment approach.
